Vaxart Enters Cooperation Agreement with Stockholder Group and Announces Board and Corporate Governance Enhancements

Vaxart resolved a proxy contest by entering a cooperation agreement with a dissident stockholder group, averting a potentially disruptive vote at the upcoming annual meeting. The company agreed to appoint a mutually agreed-upon independent director within 90 days, while the investors withdrew their nominations for three board seats.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.